Podcasts / RSV update
Save
0.5 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.
Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.
67 % of GPs rated this lecture as excellent
In this Healthed lecture, Professor Paul Griffin provides a timely update on all that treating health professionals need to know about these vaccines including the current ATAGI recommendations on who should be vaccinated and when, their effectiveness, side-effects, cost and the practical differences between Arexvy and Abrysvo, the two RSV vaccines currently available.
This educational activity was developed by Healthed at the request of and with funding from GSK.
Multiple Sclerosis vs Antibody Disease – What GPs Need to Know
Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs
Menopause and MHT: Maximising Benefits & Minimising Risks
Peripheral Arterial Disease
expert
Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland
Browse the latest podcasts from Healthed.
You have completed the Educational Activities (EA) component of this activity.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease